Digital Technology for High Blood Pressure

N/A

Recruiting

Led By Kathleen Insel, PhD

Research Sponsored by University of Arizona

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 4, week 12

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing the effectiveness of a smartphone app in helping older adults with mild cognitive impairment to better adhere to their high blood pressure medications. 100 participants will be recruited and split into two groups,

Who is the study for?

This trial is for older adults with mild cognitive impairment (MCI) who also have high blood pressure. Participants should be able to use a smartphone and willing to be monitored for their medication adherence over 16 weeks.

What is being tested?

The MedManage study tests a smartphone app designed to help manage hypertension medications. There are two groups: one uses the app with reminders and education (MedManage-S), while the other receives only educational information (MedManage-P).

What are the potential side effects?

Since this trial involves using digital technology rather than medication, there are no direct medical side effects. However, participants may experience frustration or difficulty if they're not tech-savvy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 4, week 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 4, week 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 4, week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in medication adherence measured by the Medication Event Monitoring System (MEMS® Cap)

Change in self-reported medication adherence measured by the Medication Adherence Report Scale-5 (MARS-5© Professor Rob Horne)

Secondary study objectives

Change in Systolic and/or Diastolic blood pressure, as measured by taking blood pressure readings

Change in hypertension knowledge measured by the Hypertension Knowledge-Level Scale

System Usability measured by the System Usability Scale

Other study objectives

Opinion Interview

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: bpMedManage-SExperimental Treatment1 Intervention

Intervention group will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. They will complete immediate outcomes assessment 4 weeks after the beginning of the intervention and follow-up outcomes 12 weeks after the beginning of intervention.

Group II: bpMedManage-PActive Control1 Intervention

Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on the education portal. They will complete immediate outcomes assessment 4 weeks after the beginning of the intervention and follow-up outcomes 12 weeks after the beginning of intervention.

Do I qualify?Apply below to find out